Amniotic fluid and placental stem cells as a source for urological regenerative medicine

Paolo De Coppi, Georg Bartsch, Anthony Atala

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.

Original languageEnglish
Title of host publicationBiomaterials and Tissue Engineering in Urology
PublisherElsevier Ltd.
Pages378-394
Number of pages17
ISBN (Print)9781845694029
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Regenerative Medicine
Amniotic Fluid
Stem Cells
Amniocentesis
Embryonic Stem Cells
Prenatal Diagnosis
Mesenchymal Stromal Cells
Placenta
Research

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

De Coppi, P., Bartsch, G., & Atala, A. (2009). Amniotic fluid and placental stem cells as a source for urological regenerative medicine. In Biomaterials and Tissue Engineering in Urology (pp. 378-394). Elsevier Ltd.. https://doi.org/10.1533/9781845696375.3.378

Amniotic fluid and placental stem cells as a source for urological regenerative medicine. / De Coppi, Paolo; Bartsch, Georg; Atala, Anthony.

Biomaterials and Tissue Engineering in Urology. Elsevier Ltd., 2009. p. 378-394.

Research output: Chapter in Book/Report/Conference proceedingChapter

De Coppi, P, Bartsch, G & Atala, A 2009, Amniotic fluid and placental stem cells as a source for urological regenerative medicine. in Biomaterials and Tissue Engineering in Urology. Elsevier Ltd., pp. 378-394. https://doi.org/10.1533/9781845696375.3.378
De Coppi P, Bartsch G, Atala A. Amniotic fluid and placental stem cells as a source for urological regenerative medicine. In Biomaterials and Tissue Engineering in Urology. Elsevier Ltd. 2009. p. 378-394 https://doi.org/10.1533/9781845696375.3.378
De Coppi, Paolo ; Bartsch, Georg ; Atala, Anthony. / Amniotic fluid and placental stem cells as a source for urological regenerative medicine. Biomaterials and Tissue Engineering in Urology. Elsevier Ltd., 2009. pp. 378-394
@inbook{5fca00f26859415d936772162fb3b950,
title = "Amniotic fluid and placental stem cells as a source for urological regenerative medicine",
abstract = "Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.",
author = "{De Coppi}, Paolo and Georg Bartsch and Anthony Atala",
year = "2009",
month = "4",
day = "1",
doi = "10.1533/9781845696375.3.378",
language = "English",
isbn = "9781845694029",
pages = "378--394",
booktitle = "Biomaterials and Tissue Engineering in Urology",
publisher = "Elsevier Ltd.",

}

TY - CHAP

T1 - Amniotic fluid and placental stem cells as a source for urological regenerative medicine

AU - De Coppi, Paolo

AU - Bartsch, Georg

AU - Atala, Anthony

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.

AB - Stem cells capable of differentiating to multiple lineages may be valuable for urological regenerative medicine. Recent research has described the presence in the amniotic fluid of stem cells with various differentiative and proliferative potentials. The use of amniotic fluid-derived stem cells does not present the same ethical challenges as the use of embryonic stem cells and the cells can be isolated using amniocentesis, a widely accepted procedure for prenatal diagnosis. This chapter summarizes the different progenitor cells that have been described so far in the amniotic fluid and the placenta and focuses in particular on mesenchymal stem cells and amniotic fluid-derived stem cells.

UR - http://www.scopus.com/inward/record.url?scp=84902402573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902402573&partnerID=8YFLogxK

U2 - 10.1533/9781845696375.3.378

DO - 10.1533/9781845696375.3.378

M3 - Chapter

AN - SCOPUS:84902402573

SN - 9781845694029

SP - 378

EP - 394

BT - Biomaterials and Tissue Engineering in Urology

PB - Elsevier Ltd.

ER -